The Journal of Urology
Volume 182, Issue 6 , Pages 2569-2577, December 2009

Phosphatidylinositol-3-Kinase/Akt Signaling Pathway and Kidney Cancer, and the Therapeutic Potential of Phosphatidylinositol-3-Kinase/Akt Inhibitors

  • Camillo Porta

      Affiliations

    • Financial interest and/or other relationship with Bayer-Schering, Pfizer Oncology, Hoffman La Roche, Novartis and Wyeth.
    • Corresponding Author InformationCorrespondence: Medical Oncology and Laboratory of Pre-Clinical Oncology and Developmental Therapeutics, Istituto Di Ricovero e Cura a Carattere Scientifico San Matteo University Hospital Foundation, Piazzale C. Golgi 19, I-27100 Pavia, Italy (telephone: +39-0382-501355; FAX: +39-0382-526223)
    • ,
  • Robert A. Figlin

      Affiliations

    • Financial interest and/or other relationship with Wyeth.

Medical Oncology and Laboratory of Pre-Clinical Oncology and Developmental Therapeutics, Istituto Di Ricovero e Cura a Carattere Scientifico San Matteo University Hospital Foundation, Pavia, Italy, and Division of Medical Oncology and Experimental Therapeutics, City of Hope National Medical Center/Beckman Research Institute, City of Hope Comprehensive Cancer Center (RAF), Duarte, California

Received 30 December 2008 published online 16 October 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Study received institutional review board approval.

 See Editorial on page 2555.

 For another article on a related topic see page 2920.

PII: S0022-5347(09)02120-X

doi:10.1016/j.juro.2009.08.085

Refers to article:

  • Cell Signaling in Kidney Cancer , 19 October 2009

    Rosalyn Adam
    The Journal of Urology December 2009 (Vol. 182, Issue 6, Pages 2555-2556)

  • Expression Profile of the Polycomb Group Protein Enhancer of Zeste Homologue 2 and its Prognostic Relevance in Renal Cell Carcinoma , 20 October 2009

    Stefan Hinz, Steffen Weikert, Ahmed Magheli, Michèle Hoffmann, Rainer Engers, Kurt Miller, Carsten Kempkensteffen
    The Journal of Urology December 2009 (Vol. 182, Issue 6, Pages 2920-2925)

The Journal of Urology
Volume 182, Issue 6 , Pages 2569-2577, December 2009

Article Tools

* Image Usage & Resolution